Gaush Meditech Ltd (FRA:F7Y)

Gaush Meditech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,439	1,428	1,406	1,254	1,298	962.08
Revenue Growth (YoY)	6.82%	1.58%	12.16%	-3.42%	34.94%	-13.06%
Cost of Revenue	768.17	774.43	721.64	632.54	696.61	525.91
Gross Profit	671.28	653.96	684.6	621.25	601.61	436.17
Selling, General & Admin	390.15	378.36	378.21	333.94	320.99	250.9
Research & Development	86.68	78.42	52.88	41.09	23.51	3.14
Other Operating Expenses	30.24	31.61	0.2	19.19	13.8	1.57
Operating Expenses	507.06	488.39	431.3	394.21	358.3	255.61
Operating Income	164.22	165.58	253.3	227.03	243.32	180.56
Interest Expense	-26.66	-36.71	-50.61	-42.68	-83.53	-3.08
Interest & Investment Income	3.18	3.18	6.58	4.68	2.02	3.13
Currency Exchange Gain (Loss)	2.41	-	15.56	-172.47	61.82	18.32
Other Non Operating Income (Expenses)	17.38	19.52	18.8	16.43	13.97	12.73
EBT Excluding Unusual Items	160.52	151.56	243.63	32.99	237.6	211.66
Gain (Loss) on Sale of Investments	3.72	3.72	3.96	-307.42	-375.51	-62.36
Gain (Loss) on Sale of Assets	-	-	0.15	-0.67	-0.05	-0.14
Pretax Income	164.25	155.29	247.74	-275.09	-137.96	149.16
Income Tax Expense	66.76	66.76	74.82	77.62	53.61	50.62
Earnings From Continuing Operations	97.49	88.52	172.91	-352.71	-191.57	98.54
Minority Interest in Earnings	4.41	3.87	0.61	3.09	1.12	0.83
Net Income	101.89	92.39	173.52	-349.62	-190.45	99.37
Net Income to Common	101.89	92.39	173.52	-349.62	-190.45	99.37
Net Income Growth	12.34%	-46.75%	-	-	-	-
Shares Outstanding (Basic)	147	148	148	97	96	105
Shares Outstanding (Diluted)	147	148	148	97	96	105
Shares Change (YoY)	-0.77%	-0.14%	52.69%	1.16%	-9.03%	-3.28%
EPS (Basic)	0.69	0.63	1.17	-3.61	-1.99	0.94
EPS (Diluted)	0.69	0.63	1.17	-3.61	-1.99	0.94
EPS Growth	13.36%	-46.68%	-	-	-	-
Free Cash Flow	-	93.12	214.11	189.03	137.94	128.23
Free Cash Flow Per Share	-	0.63	1.45	1.95	1.44	1.22
Dividend Per Share	-	0.282	0.998	-	-	-
Dividend Growth	-	-71.77%	-	-	-	-
Gross Margin	46.63%	45.78%	48.68%	49.55%	46.34%	45.34%
Operating Margin	11.41%	11.59%	18.01%	18.11%	18.74%	18.77%
Profit Margin	7.08%	6.47%	12.34%	-27.88%	-14.67%	10.33%
Free Cash Flow Margin	-	6.52%	15.23%	15.08%	10.63%	13.33%
EBITDA	221.43	222.68	306.06	271.91	287.2	185.27
EBITDA Margin	15.38%	15.59%	21.77%	21.69%	22.12%	19.26%
D&A For EBITDA	57.21	57.1	52.76	44.87	43.88	4.71
EBIT	164.22	165.58	253.3	227.03	243.32	180.56
EBIT Margin	11.41%	11.59%	18.01%	18.11%	18.74%	18.77%
Effective Tax Rate	40.64%	42.99%	30.20%	-	-	33.94%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.